10 unknown, 9 completed, 2 recruiting, 2 withdrawn. 24 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 24 | Unknown 10, Completed 9, Recruiting 2, Withdrawn 2, Not yet recruiting 1 |
Follow Radiotherapy: new trials by email Literature Review of Radiotherapy trials Research Report on Radiotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Next Generation STAR-TREC (NG-ST) - Organ Preservation in Early Rectal Cancer Capecitabine + Radiotherapy, Total Mesorectal Excision (TME) - Rectal Cancer | Phase 4 | Not yet recruiting | Vastra Gotaland Region | 90 | 2026-03-12 | 2026-03-19 |
| Radiotherapy Compared to Corticosteroid Injection for Treatment of Hand Osteoarthritis Corticosteroid injection (CSI), Low-dose radiotherapy (LDRT) - Osteoarthritis Hand, Osteoarthritis Wrist | Phase 4 | Recruiting | Mayo Clinic | 165 | 2025-12-19 | 2026-04-24 |
| Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. Deferred Cytoreductive Nephrectomy + medical treatment, Radiotherapy + medical treatment, Medical therapy - Renal Cell Cancer, Kidney Neoplasm | Phase 4 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 409 | 2025-06-15 | 2025-07-03 |
| Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES) Tislelizumab + cisplatin + paclitaxel, Tislelizumab + radiotherapy - Esophageal Squamous Cell Carcinoma | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 32 | 2022-10-10 | 2023-06-29 |
| Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis Donafenib - HCC, Chemotherapy Effect | Phase 4 | Unknown | Anhui Provincial Hospital | 30 | 2021-09-30 | 2021-09-21 |
| Total Neoadjuvant Therapy in Rectal Cancer Treatment Concurrent Chemoradiotherapy, TME, consolidation chemotherapy - Rectal Cancer | Phase 4 | Unknown | State Scientific Centre of Coloproctology, Russian Federation | 280 | 2020-10-30 | 2021-02-15 |
| Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT) Endocrine Therapy and Radiotherapy - Early-stage Breast Cancer | Phase 4 | Completed | Ottawa Hospital Research Institute | 262 | 2019-09-17 | 2022-09-30 |
| Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung Cancer Zoledronic acid, Radiotherapy - Non-small Cell Lung Cancer, Bone Metastasis | Phase 4 | Unknown | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 280 | 2019-06-01 | 2019-01-16 |
| Radiotherapy Dose Escalation in Locally Advanced Squamous Cell Carcinoma of the Larynx or Hypopharynx Radiation Therapy, Chemotherapy - Advanced Squamous Cell Carcinoma | Phase 4 | Withdrawn | University of Florida | 2019-02-04 | 2019-05-13 | |
| Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer Resection, Radiotherapy, Chemotherapy - Oropharyngeal Cancer | Phase 4 | Unknown | Universitätsklinikum Hamburg-Eppendorf | 280 | 2018-01-05 | 2023-05-17 |
| Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy According to the Laser Density for Actinic Keratosis lidocaine/prilocaine (5%) application, 2940-nm Er:YAG AFL pretreatment, MAL application - Actinic Keratosis | Phase 4 | Completed | Dong-A University | 47 | 2017-02-01 | 2018-11-06 |
| The Optimal Neck Treatments Strategy of Early Oral Cancer Based on Adverse Pathological Factor Radiotherapy, Elective neck dissection - Oral Cancer | Phase 4 | Unknown | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 270 | 2016-07-01 | 2017-01-11 |
| Treatment of Natural Killer/T Cell Lymphoma-I/II DDGP(cisplatin,dexamethasone,gemcitabine,pegaspargase), VIPD(cisplatin,Etoposide,Ifosfamide, dexamethasone,Mesna), gemcitabine,pegaspargase,cisplatin,dexamethasone - Nasal and Nasal-type NK/T-cell Lymphoma | Phase 4 | Unknown | Mingzhi Zhang | 200 | 2011-01-01 | 2015-07-17 |
| Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC) radiotherapy combined with EP, radiotherapy / EP combined with recombinant human endostatin - Non-small Cell Lung Cancer | Phase 4 | Unknown | Simcere Pharmaceutical Co., Ltd | 170 | 2010-10-01 | 2010-09-29 |
| p53 Gene Therapy for Head and Neck Malignant Tumors in Advanced Stage chemotherapy plus p53, chemotherapy, radiotherapy - Neoplasms | Phase 4 | Unknown | Shenzhen SiBiono GeneTech Co.,Ltd | 1200 | 2009-05-01 | 2012-04-09 |
| Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572) Temozolomide, Radiotherapy - Glioblastoma | Phase 4 | Completed | Merck Sharp & Dohme LLC | 99 | 2008-06-24 | 2017-06-14 |
| Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast Cancer Electronic Brachytherapy, Intracavitary accelerated partial breast irradiation - Breast Cancer, Carcinoma | Phase 4 | Completed | Xoft, Inc. | 63 | 2008-05-01 | 2016-05-17 |
| Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC) Concurrent chemoradiotherapy (paclitaxel plus cisplatin plus radiotherapy) - Non-small-cell Lung Cancer | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 6 | 2008-04-01 | 2011-09-15 |
| Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX Casodex 150mg, Radiotherapy, Haematology - Prostate Cancer | Phase 4 | Completed | AstraZeneca | 125 | 2003-06-01 | 2008-01-25 |
| Epoetin Beta in Treating Anemia in Patients With Cervical Cancer epoetin beta, cisplatin, brachytherapy - Anemia, Cervical Cancer | Phase 4 | Completed | AGO Study Group | 450 | 2002-07-01 | 2013-05-30 |
Showing 20 of 24. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (3) · Anemia (2) · Breast Neoplasms (2) · Hodgkin Disease (2) · Rectal Neoplasms (2) · Blast Crisis (1) · Burkitt Lymphoma (1) · Carcinoma (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Carcinoma, Renal Cell (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Esophageal Squamous Cell Carcinoma (1) · Glioblastoma (1) · Graft vs Host Disease (1) · Keloid (1)
AGO Study Group (1) · Anhui Provincial Hospital (1) · AstraZeneca (1) · Charite University, Berlin, Germany (1) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1) · Dong-A University (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Mayo Clinic (1) · Merck Sharp & Dohme LLC (1) · Mingzhi Zhang (1) · Ottawa Hospital Research Institute (1) · Queen Mary University of London (1) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1) · Shenzhen SiBiono GeneTech Co.,Ltd (1)
China (5) · Germany (4) · United States (4) · Canada (1) · Italy (1) · Russia (1) · South Korea (1) · Taiwan (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Barry R. Meisenberg, MD (1) · Chia-Jung Busch, PD Dr. (1) · Eckhard Thiel, MD (1) · Evgeny Rybakov, Dr.Med.Sc (1) · Ge Wang, Doctor (1) · Haluk Ozen, Prof (1) · Heinz Koelbl, MD (1) · Jean Marc Bourque, MD (1) · Junke Fu (1) · Ki-hoon Song, MD (1) · Mingzhi Zhang, Pro,Dr (1) · Peter Beitsch, MD (1) · Rakesh Patel, MD (1) · Ralph Naumann, MD (1)
PMID 19484483, PMID 20970380, PMID 23053582, PMID 26481741, PMID 32727416, PMID 33034052, PMID 37650478, PMID 42433301
2025 (1)